Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Meet the team
 
Eleanor Malone

Eleanor Malone

Eleanor.Malone@informa.com

@ScripEleanor

Eleanor has been editor of Scrip since 2014. She has more than 15 years' experience writing specialist news and analysis for and about the biopharma industry. She holds an MA in modern languages from the University of Edinburgh. Based in London, she appears regularly on TV and radio and conference panels to discuss matters related to the industry.

Read more »


Denise Peterson

Denise Peterson

Denise.Peterson@informa.com

@PinkSheetDenise

Denise has had a colorful history reporting as a senior editor on numerous issues for publications now part of Informa's Pink Sheet and Scrip resources. Those include "The Pink Sheet,""The Blue Sheet" (NIH and public health programs), "The Beige Sheet" (medical technology reimbursement) and Medicare Drug Focus. Her areas of particular expertise include Capitol Hill and health care reimbursement. She is inspired daily by the talented and knowledgeable US editorial team, and helps them provide the highest quality strategic insights for pharma's regulatory and commercial readers. She is based in Informa's flagship Washington, D.C. office.

Read more »


Ian Haydock

Ian Haydock

Ian.Haydock@informa.com

@ScripIanHaydock

Ian oversees pharma news content for the Asia-Pacific area and has been covering the region for more than 20 years as an editor for Scrip and more recently as managing editor of PharmAsia News. He has a long background in Asia, having grown up in Hong Kong, and a particular interest in regional regulatory harmonization and trade initiatives and the development of the Japanese pharma sector. Ian lives in Tokyo with his wife and two sons.

Read more »

 

COMMERCIAL

EUROPE

 
Alex Shimmings

Alexandra Shimmings

Alex.Shimmings@informa.com

@ScripAlexS

Alexandra has more than 20 years' experience covering pharmaceutical and biotech R&D. An early interest in medicine, and a dawning realization that being a doctor was not for her, led to a degree in Biochemistry and Microbiology at the University of Leeds, and a move to London to pursue a career in medical journalism. Now Scrip's Managing Editor, Alex has held a variety of roles on the publication since starting as a science reporter in 1998. She instigated some of Scrip's signature features, such as the Pipeline Watch and New Active Substance lists, and also casts an editorial eye over the annual Scrip Awards. Alex's main work interests lie in novel drugs and pharmaceutical and biotech R&D, and she also enjoys medical history and current affairs.

Read more »


Lubna Ahmed

Lubna Ahmed

Lubna.Ahmed@informa.com

@ScripLubna

Lubna Ahmed joined the Scrip editorial team in 2015 as a shiny new graduate in human biology and journalism, an interesting combination and perfect prologue to a career with Scrip. She is particularly interested in digital medicine and technology, social media, and who is moving where within the pharma industry. Lubna has a surprisingly large Twitter following for a non-celebrity, and when she isn't reading, writing or editing pharma-related news and analysis, she can be found eating chocolate and composing tweets to keep the Twittersphere entertained.

Read more »


Francesca Bruce

Francesca Bruce

Francesca.Bruce@informa.com

@ScripFrancesca

Francesca Bruce has been writing news and analysis about all things affecting the pharmaceutical industry since 2008. She has paid special attention to policy and regulatory developments but particularly likes to write about market access and how medicines may - or may not - make it to patients. She generally writes about Europe, but really enjoys uncovering news from further corners of the globe, especially Latin America and the Middle East.

Read more »


Peter Charlish

Peter.Charlish@informa.com

@PeterCharlish

Peter originally trained as a pharmacologist and has been following the fortunes of the pharmaceutical and medtech industries for over 35 years. During that time he has interviewed many people, attended many conferences and trade shows, and has visited companies large and small. He has written items for newsletters, feature articles for magazines, as well as longer in-depth reports. He has also spoken on healthcare-related matters at a number of international conferences. Out of all that has come a passion to understand what drives individuals and organisations to push back the frontiers of knowledge for the overall benefit of mankind. In his spare time he likes to complain about falling standards (grammar, manners, road users who don't indicate), and he has little time for those who use management gobbledegook.

Read more »


John Davis

John Davis

John.Davis@informa.com

A journalist and editor for more than 30 years, John has a broad interest in pharmaceuticals-related health care policy and breakthroughs in scientific and medical research.  He has degrees in biology and biochemical pharmacology.

Read more »


Lucie Ellis

Lucie Ellis

Lucie.Ellis@informa.com

@ScripLucie

Lucie Ellis, based in the UK, joined the Scrip team in 2012. In her current position as a Creative Content Reporter, she is focused on introducing innovative and imaginative ways to display content on the web. As a reporter covering the pharma and biotech world, Lucie understandably spends a lot of her time writing about drugs and money or Googling abbreviations. However she has a particular interest in employment trends, social and digital media use by industry, patient-centricity, big data, and clinical research in the metabolic and CNS fields. Lucie enjoys traveling and can often be seen out and about at industry events across the globe as Scrip’s roving reporter.

Read more »


John Hodgson

John Hodgson

John.Hodgson@informa.com

@ScripJohn

John is Data Editor, Pharma within Informa's Pharma Intelligence division. He honed skills as a writer, analyst and consultant, commentating on science and business in biotechnology over three decades. He prefers evidence to received wisdom, and believes that new is interesting but improved is better.

Read more »


Jo Shorthouse

Jo Shorthouse

Joanne.Shorthouse@informa.com

@ScripJo

Jo Shorthouse is features editor for Scrip and manages the Scrip 100 publication. Jo has covered the biopharmaceutical industry and related service industries since 2008 when she edited Good Clinical Practice journal followed by Scrip Clinical Research. Before this, she worked at various publications covering topics such as chemical logistics, the advertising industry and the property market.

Read more »


Sten Stovall

Sten.Stovall@informa.com

@StenStovall

Sten Stovall is a London-based editor and writer with 40 years of experience in the field of journalism, including more than 20 years with Reuters and eight years with The Wall Street Journal/Dow Jones Newswires. He also has wide radio and television reporting experience and a solid network of contacts in the biopharma world. Sten is part of our team of specialist reporters, generating insightful features and analysis about R&D, product development, regulatory issues and industry trends for publications such as "The Pink Sheet", Scrip and IN VIVO.

Read more »


US

 

Mary Jo Laffler

Maryjo.Laffler@informa.com

@PinkSheetMaryJo

Mary Jo Laffler oversees commercial content for Informa’s pharmaceutical news publications, working with a group of talented reporters and editors covering business, commercial and clinical news. She brings 15 years of experience reporting on the pharmaceutical industry for “The Pink Sheet” and affiliated publications, serving previously as Bureau Chief for Clinical Development and Business News, Managing Editor of “The Pink Sheet” and as one of the original Managing Editors for “The Pink Sheet” DAILY. While wearing many hats has given Mary Jo a wide-ranging knowledge of the commercial and regulatory challenges facing the pharmaceutical industry, her specialty is in analyzing drug development news and R&D strategy.

Read more »


Emily Hayes

Emily Hayes

Emily.Hayes@informa.com

@EmilyKateHayes

Emily Hayes is a writer/editor with over 20 years’ experience in medical journalism, including magazines for specialist clinicians, government health publications, business newswires and pharma trade press.  Her educational background lies in journalism and political science. Emily has dual citizenship and has experience working in the UK and US. Since 2008, she has been a senior writer on staff with “The Pink Sheet,” working out of her home base in biopharma hub San Francisco. She enjoys covering drug development, with special areas of focus in cancer, particularly immunotherapy, and cardiology/metabolics. She covers major scientific meetings regularly, including the American Society of Clinical Oncology, and appreciates interactions with key opinion leaders while interpreting drug trial results. In her free time, she is a professional jazz/blues/country vocalist.

Read more »


Joseph Haas

Joseph.Haas@informa.com

Joseph Haas is a senior writer for Informa’s pharmaceutical news publications, with more than eight years covering the biopharmaceutical industry. He previously worked in public affairs for a real estate trade association and wrote about housing and real estate before moving into healthcare. Most recently, he was managing editor of a newsletter publisher, leading its coverage of the implementation of the Medicare Part D prescription drug benefit. Joe’s areas of expertise include business development, mergers and acquisitions, infectious diseases and liver diseases, including hepatitis C, hepatitis B and non-alcoholic steatohepatitis (NASH). He edits the popular Deal Watch column and enjoys profiling start-up companies. 

Read more »


Mandy Jackson

Mandy.Jackson@informa.com

@ScripMandy

Mandy Jackson is the US West Coast Editor for Scrip. Mandy reports on daily biopharma news and regularly interviews everyone from big pharma CEOs to biotech startup founders about the business strategy behind their finance, dealmaking and drug development news. She also has an interest in drug pricing and novel reimbursement strategies, new treatments in areas of true unmet need, and business development trends. Mandy has been a business news reporter for more than 15 years, covering biotech and pharma companies, biotech law and commercial real estate. She is based in San Diego, California – the venue for many medical and biopharma industry meetings.

Read more »

 

Jessica Merrill

Jessica.Merrill@informa.com

@Jessicaemerrill

Jessica Merrill is a Bureau Editor for US Commercial Content for Informa’s pharmaceutical news publications, including “The Pink Sheet” and SCRIP. She has been covering the pharmaceutical industry as a journalist for more than 10 years, spanning the spectrum from R&D to regulatory to commercial. She was previously a reporter and editor for “The Pink Sheet” and “Pink Sheet” DAILY, specializing in business and commercial news, focusing largely on big pharma, M&A and business development, and the commercial landscape, including drug launches and market access. Before embarking on a career in healthcare journalism, she covered business news for the cosmetics industry and worked as a newspaper reporter.

Read more »

 

POLICY & REGULATORY

EUROPE

 
 Maureen Kenny

Maureen Kenny

Maureen.Kenny@informa.com

@ScripRegMaureen

Maureen's expertise in bringing exclusive, business-critical content to the expanded Pink Sheet audience builds upon her many years' experience as an editor and reporter. Most recently, Maureen headed Scrip Regulatory Affairs, an indispensable publication for both pharmaceutical and medtech regulatory affairs professionals worldwide. She managed the publication's move from print to digital. Previous leadership roles also include being editor of Clinica Medtech Intelligence and acting editor of Scrip Intelligence. She chaired the DIA EuroMeeting plenary session in Paris in April 2015 and spent two years in New York covering the pharmaceutical industry in the US, Canada and, being a fluent Spanish speaker, Latin America. Maureen is based in London.

Read more »


Neena Brizmohun

Neena Brizmohun

Neena.Brizmohun@informa.com

@ScripRegNeena

Neena Brizmohun writes and commissions news, features and analysis to meet the regulatory, business and market access information needs of the companies and regulatory agencies that operate in the pharmaceutical and medical device space worldwide.

Her areas of expertise include the cutting-edge early market access schemes that are being trialed around the world for taking drugs and medical devices to market faster. She is also interested in initiatives for harmonizing regulations at the global level as well as issues affecting clinical trials, manufacturing and post-market safety monitoring. She explores the challenges and opportunities that these issues introduce for both industry and the regulators and is on a constant look out for what might be coming next.

A scientist by training, Neena started her journalistic career at Informa in 1997. She has been the deputy editor of Scrip Regulatory Affairs since 2007. Prior to that, she worked as the science editor for Clinica Medtech Intelligence. Before becoming a journalist she worked as a biomedical scientist at St Thomas' Hospital in London for 10 years.

Read more »


Ian Schofield

Ian.Schofield@informa.com

@ScripIanS

Ian Schofield writes on a range of issues affecting the pharmaceutical industry, with a focus on EU and global regulatory, political and scientific affairs. Having graduated in modern languages at the University of Bath in 1979, he worked in the European travel industry before joining Scrip World Pharmaceutical News as a reporter in 1985, covering the French and Italian markets. He later became Deputy Editor with responsibility for EU regulatory affairs, a post he held until 2005 when he took on the role of Consultant Editor to a number of Informa publications including Scrip and the Regulatory Affairs Journal. In July 2008 Ian became a Principal Analyst for Informa Business Information, covering global regulatory and legal issues in areas such as clinical trials, bioisimilars, orphan drugs, and pricing and reimbursement. As well as writing news, features and analysis for Scrip, Scrip Regulatory Affairs, the Pink Sheet and In Vivo, Ian is part of the Ask the Analyst team that produces on-demand tailored reports for subscribers.

Read more »


Vibha Sharma

Vibha Sharma

Vibha.Sharma@informa.com

@ScripRegVibha

Vibha Sharma is a senior reporter covering pharmaceutical and medtech regulatory developments across the globe. She joined Scrip Regulatory Affairs in September 2010 and has since then been at the center of deciding and writing news on important regulatory issues affecting the pharma and medtech sectors and explaining their implications for the industry.

Her fields of interest include the EU Pharmacovigilance legislation and the EU Paediatrics Regulation on which she has written several exclusive articles from various industry conferences. She has also commissioned some pieces of expert analysis on major developments in the pharma and medtech regulatory arenas.

Before joining Informa, she was principal correspondent with India's national newspaper Hindustan Times, where she reported on health and medical issues, besides several other topics. She has also worked with two other Indian national dailies, The Indian Express and The Asian Age.

Read more »

 

US

 
Matthew Hobbs

Nielsen Hobbs

Nielsen.Hobbs@informa.com

M. Nielsen Hobbs has more than 20 years of experience covering the pharmaceutical industry, and writes frequently about the intersection of business, regulation, science and politics. Before joining the "The Pink Sheet" he worked for Congressional Quarterly. Hobbs enjoys discussing BB-8 almost as much as he enjoys talking about 351(k).

Read more »


Michael Cipriano

Michael.Cipriano@informa.com

@mcipriano93

Michael Cipriano is a writer based in Washington, D.C. who covers FDA regulatory policy. He has primarily written about advisory committees, FDA public meetings and drug regulation. He is also part of the Pink Sheet's efforts to expand coverage into Latin America. Previously, Michael has covered generic drug and biosimilar regulation, as well as issues impacting clinical trials.

Read more »


Bowman Cox

Bowman Cox

Bowman.Cox@informa.com

@GoldSheetBowman

Bowman Cox leads the Pink Sheet's coverage of pharmaceutical manufacturing quality issues. He writes and edits articles on the challenges and opportunities that developments in science, technology and regulatory policy pose to drug manufacturers and their quality organizations.

Read more »


 Joanne Eglovitch

Joanne Eglovitch

Joanne.Eglovitch@informa.com

Joanne Serpick Eglovitch was a senior editor for "The Gold Sheet" where she writes about manufacturing quality issues. Joanne has over 20 years of experience covering the regulated pharmaceutical and medical device industries, and helped launch the "International Pharmaceutical Regulatory Monitor" and the "International Medical Device Regulatory Monitor". Previously Joanne covered the mortgage finance industry and the mortgage capital markets, and employment and training programs. Before her forays into newsletter journalism, Joanne worked as a general assignment reporter for a twice-weekly newspaper in southern Maryland and an editorial assistant for "Insight" Magazine, published by "The Washington Times."

Read more »


Eileen Francis

Eileen Francis

Eileen.Francis@informa.com

Eileen Francis is a reporter for "The Tan Sheet," where she follows news on OTC drug and nutritional product manufacturing, regulation, legislation, finance and research. She previously served as a reporter and editor of "The Rose Sheet," IBI's source for in-depth coverage of the cosmetics industry. Early in her career, Eileen worked in public relations and as a writer for a lobbying firm. Outside of IBI, her freelance work includes articles on business, art and travel

Read more »


Derrick Gingery

Derrick Gingery

Derrick.Gingery@informa.com

@dgingery

Senior writer Derrick Gingery has been reporting on regulatory issues for "The Pink Sheet" and "The Pink Sheet" Daily since 2010. Among his favorite topics are FDA's user fee programs, along with generic drug and biosimilar policy, but he also handles drug approval issues and general FDA news.

An award-winning journalist, Derrick has written extensively about user fee negotiations, the FDA budget, FDA travel restrictions and drug advertising compliance. He also was part of the Pink Sheet team covering FDA's first biosimilar advisory committee meetings.

When he's not following FDA, Derrick is keeping close tabs on Indiana Hoosiers basketball.

Read more »


Cathy Kelly

Cathy Kelly

Cathy.Kelly@informa.com

Cathy Kelly has been covering reimbursement and market access news for more than a decade for "The Pink Sheet" and other publications that are now part of Informa's pharmaceutical intelligence resources. Her expertise spans legislative, regulatory and public policy topics as well as coverage trends in public and private insurance markets. Cathy is especially interested in following the ongoing transformation of the US health care system and its effect upon major stakeholders in the biopharma industry. She is based in Washington D.C.

Read more »


Brenda Sandburg

Brenda Sandburg

Brenda.Sandburg@informa.com

@brendasandburg

Brenda Sandburg is a senior writer who covers legal issues and FDA regulatory policy, with a particular focus on patents, biosimilars, and government investigations. She spent 10 years writing for legal publications between stints at The Pink Sheet and blends these experiences to provide in-depth analysis of events. An aspiring photographer, she enjoys taking photos to accompany news stories.

Read more »


Bridget Silverman

Bridget Silverman

Bridget.Silverman@informa.com

Bridget Silverman has been covering FDA for "The Pink Sheet" since David Kessler was commissioner. She keeps watch on the drug review process for the FDA Performance Tracker and the Drug Review Profile series. In her down time, Bridget reads mystery novels and keeps track of her family and three dogs.

Read more »


Malcolm Spicer

Malcolm Spicer

Malcolm.Spicer@informa.com

Mr. Spicer is lead analyst for Pharma intelligence | informa's coverage of the consumer health care products industries. He provides comprehensive and insightful reporting on manufacturing, marketing, regulation, legislation, financial and research news about the nonprescription drug and nutritional product industries. He has worked in this post for 10 years and previously reported for other publications on regulation of the health care industry, on the telecommunications and internet technologies and on the US energy market.

Read more »


Sue Sutter

Sue Sutter

Sue.Sutter@informa.com

@PinkSheetSutter

Sue is a senior editor with Pink Sheet, where she writes primarily about drug, biologic and biosimilar regulation, FDA advisory committees and product approvals. She has reported on the prescription and over-the-counter drug industries since 1999 for various publications now under the umbrella of Informa Business Information, including Pink Sheet, "The Pink Sheet" DAILY, "The Tan Sheet" and Scrip. Previously she worked as an editor for Mealey's Litigation Reports (now part of Lexis-Nexis), writing about asbestos, toxic tort and fen-phen litigation.

Read more »

 

ASIA

 
Anju Ghanguarde

Anju Ghangurde

Anju.Ghangurde@informa.com

@ScripAnjuG

Anju Ghangurde is Scrip's Deputy Asia Editor and has about two decades of experience in journalism including stints at India's mainstream financial dailies -The Economic Times, The Hindu Business Line and The Financial Express. She covers a broad range of issues including competition and collaboration between generics and innovator firms, drug pricing and the evolving regulatory and legal framework in the region. She is also a recipient of the British Chevening Scholarship for Young Indian Journalists (2000-01) awarded by the Foreign & Commonwealth Office.

Read more »


Ying Huan

Ying Huang

Ying.Huang@informa.com

@YingHuang_

Ying Huang Areas of expertise: China commercial pharma and biotech sector including ventures, financing, strategy and mergers.

Ying is China Commercial Editor with PharmAsia News. She has been working with international healthcare business intelligence since 2007, covering China and South East Asian countries including Singapore, Taiwan, Thailand, Vietnam, the Philippines, Malaysia and Indonesia. Her work covers health care reform, new drug development, M&A and financing, partnering, business strategies and outsourcing. Prior to joining Informa, Ying was the China Bureau Editor of BioPharm Insight, a Financial Times Group product. She led the investigative coverage on the important situations taking place within the healthcare industry, delivering breaking news and insights on the biopharmaceutical industry in China and Southeast Asia.

Ying has covered academic and industry meetings in China and Asia where she has interviewed C-level executives and key opinion leaders. She has also worked as an international business development assistant at a China-listed pharmaceutical company.

Ying holds a Master's degree in Public Health from the University of Westminster in London, and a bachelor's degree in biotechnology.

Read more »


 Jung Won Shin

Jung Won Shin

JungWon.Shin@informa.com

Areas of expertise: South Korean pharma/bioventure sector and regulatory policy topics.

Jung Won is a reporter based in Seoul covering South Korea, most recently working for PharmAsia News. Her work covers corporate activities in the South Korean pharma/biotech sector as well as government policy and regulatory news. In her role, Jung Won focuses on R&D strategies, clinical development, licensing deals and other major corporate deals and activities in the country's pharma/biotech sector as well as major government measures or regulatory activities in the sector.

Prior to joining Informa, Jung Won worked for Dow Jones Newswires in Seoul, covering stories in various industries and government. Outside of work, she likes to travel and spend time with her family and friends.

Read more »


Brian Yang

Brian Yang

Brian.Yang@informa.com

@bhxyang

Areas of expertise: Regulatory affairs and reforms, R&D and market access issues in China.

Beijing-based Brian Yang is a senior writer in charge of overall China coverage within the APAC Pharma news team. A veteran journalist, he has written extensively on pharmaceutical R&D, regulatory affairs and market access for PharmAsia News. Brian's intimate industry knowledge and in-depth analysis has won wide praise and helped secure exclusive interviews with top biopharma executives.

He has led a team of writers to provide industry-leading coverage on key issues such as multi-regional clinical trials, priority reviews and go-to-market strategies in a highly-dynamic and fast-changing market, with the on-the-ground coverage consistently ranked among the top-read in PharmAsia News.

Prior to joining Informa, Brian worked as a foreign affairs correspondent for two TV networks and web editor for an international radio station. Trilingual in Mandarin Chinese, English and Japanese, he obtained his BA degree from China and an MA degree from Japan.

Read more »

 

LEADERSHIP

 

Mike Ward

Mike.Ward@informa.com

@ScripMikeWard

Mike has been writing, analysing and commenting on the life sciences industry for more than 30 years as a journalist and investment bank analyst. He has focused on business models, R&D strategies and how to finance innovation, and is often called upon by the industry's key stakeholders to provide thought leadership. In 2010 he was named European Mediscience Commentator of the Year and has appeared on the shortlist for that award on numerous occasions. When not commentating on all things pharma, Mike is engaged actively in pub quizzes, either as a competitor or a compiler. He is also a qualified FA soccer coach.


Phil Jarvis

Phil.Jarvis@informa.com

Phil graduated from The University of Bath in 1997 and embarked on a brief career as a crop protection research scientist. In January 2000 Phil made a sideways jump into publishing, joining PJB Publications as a report writer with the crop protection business.

Since then Phil has built his knowledge of the publishing business in a variety of content and commercial roles. In 2008 Phil moved to Informa's Pharma business as publisher of Scrip.

Phil now leads this business as 'Head of Insight' for the Pharma intelligence vertical within Informa's Business Intelligence division. He works with colleagues across the vertical to deliver an integrated, market-leading Pharma intelligence service encompassing insights, intelligence and consulting.

     
UsernamePublicRestriction

Register

Advertisement